OcyonBio closes $72M CDBG-DR loan for Aguadilla biomanufacturing campus

The $72M CDBG-DR loan, signed at the Department of Housing in San Juan, advances a campus where client companies lease cGMP suites and manufacture inside shared infrastructure.

Stands on 6 placed sources from 4 publishers.

OcyonBio has closed a $72 million loan under the Puerto Rico CDBG-DR program to finance its biomanufacturing campus in Aguadilla, with the funding administered through the Puerto Rico Department of Housing.^[1] The closing was signed at the Department of Housing in San Juan by OcyonBio co-founder and CEO Robert Salcedo, CFO Daniel Chang, and Deputy Secretary of Disaster Recovery Lcdo. Carlos R. Olmedo.^[1] The loan funds a campus that combines contract manufacturing (CDMO) and process-development (PDMO) capabilities under one roof: client companies lease fully cGMP-compliant clean rooms and suites inside shared infrastructure and run their own manufacturing autonomously - a model that cuts the capital cost of building a plant from scratch and extends a young company's runway.^[2] The Aguadilla site currently offers 200,000 square feet of customizable cleanroom space, with individual suites ranging from 200 to 50,000 square feet, serving companies working in cell and gene therapies, biologics, and viral vectors - from early research through commercial scale.^[3] OcyonBio has signed agreements to develop more than 95,000 square feet of cleanroom and biomanufacturing space at the site for Biosimilar Solutions, covering process development, plasmid DNA, viral vectors, cell banking, and cell processing.^[4] The company's staged expansion plan - eight buildings named after the world's oceans, totaling more than $200 million of investment - is scheduled to complete in 2029, adding analytical laboratories, a manufacturing science lab, and an AI-driven lab designed to train non-technical staff into biomanufacturing roles.^[5] In 2023, the Puerto Rico Economic Development Bank extended $3.85 million in equipment financing to Ocyon Bio PR and Biosimilar Sciences PR through the U.S. Treasury's State Small Business Credit Initiative.^[6]

Proof6 sources · 5 publishers · signed

What this stands on

OcyonBio closed a $72 million loan under Puerto Rico CDBG-DR program, directed by the Puerto Rico Department of Housing, to finance its biomanufacturing campus in Aguadilla. · linkedin.com
The $72M CDBG-DR program enables the creation of a campus in Aguadilla combining CDMO and PDMO capabilities, where companies receive services or lease customized cGMP clean rooms or suites and operate autonomously. · linkedin.com
OcyonBio operates a biomanufacturing campus in Aguadilla, Puerto Rico, providing customizable cGMP spaces from R&D to commercial scale for cell and gene therapies, biologics, and viral vectors. · ocyonbio.com
OcyonBio entered a manufacturing and operations agreement to develop more than 95,000 sq. ft. of cleanroom and biomanufacturing space in Aguadilla for Biosimilar Solutions, including process development, plasmid DNA, viral vectors, cell banking, and cell processing. · Contract Pharma
The OcyonBio campus expansion plans eight state-of-the-art buildings dedicated to advanced biopharmaceutical manufacturing, named after the world's oceans, with total investment exceeding $200 million; the staged plan completes in 2029 and includes analytical laboratories, a manufacturing science lab, and an AI-driven lab to train non-technical staff. · OcyonBio
In August 2023, the Puerto Rico Economic Development Bank granted $3.85 million in financing to Ocyon Bio PR Inc. and Biosimilar Sciences PR LLC for specialized biotechnology equipment, funded through the U.S. Treasury State Small Business Credit Initiative. · News is My Business

We could not place any of them by their address. None is an official body: that part stands on reporting, not on the underlying document or transcript.